An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia

Proteomics

Volumn 7, Issue 19, 2007, Pages 3569-3579

  Vercauteren, Freya G G ^a,b   Flores, Gonzalo ^a,c   Ma, Weiya ^a   Chabot, Jean Guy ^a   Geenen, Lieve ^b   Clerens, Stefan ^b   Fazel, Ali ^d   Bergeron, John J M ^d   Srivastava, Lalit K ^a   Arckens, Lutgarde ^b   Quirion, Rémi ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

2 D electrophoresis; Animal model; Organelle; Plasma membrane; Schizophrenia

Indexed keywords

BINDING PROTEIN; CLATHRIN LIGHT CHAIN; MEMBRANE RECEPTOR; NERVE PROTEIN; NEUROCALCIN; NEUROCALCIN DELTA; SYNTAXIN; UNCLASSIFIED DRUG; VISININ;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL ORGANELLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXOCYTOSIS; EXPERIMENTAL RAT; FEMALE; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; REGULATORY MECHANISM; SCHIZOPHRENIA; STATISTICAL ANALYSIS; SYNAPSE VESICLE;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; ORGANELLES; PROTEOME; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SYNAPSES; SYNAPTIC TRANSMISSION;

ANIMALIA; RATTUS;

EID: 34548343391     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700379     Document Type: Article

References (81)

1. van Os, J., Epidemiol. Psychiatr. Soc. 2003, 12, 242-252.
2. Kasper, S., Tauscher, J., Kufferle, B., Barnas, C. et al., Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249, 83-89.
3. Miyamoto, S., Duncan, G. E., Marx, C. E., Lieberman, J. A., Mol. Psychiatry 2005, 10, 79-104.
4. Weinberger, D. R., Clin. Ther. 2005, 27, S8-S15.
5. Shifman, S., Bronstein, M., Sternfeld, M., Pisante-Shalom, A. et al., Am. J. Hum. Genet. 2002, 71, 1296-1302.
6. Fujii, Y., Shibata, H., Kikuta, R., Makino, C. et al., Psychiatr. Genet. 2003, 13, 71-76.
7. Addington, A. M., Gornick, M., Duckworth, J., Sporn, A. et al., Mol. Psychiatry 2005, 10, 581-588.
8. Chen, M. L., Chen, S. Y., Huang, C. H., Chen, C. H., Mol. Psychiatry 2002, 7, 447-448
9. Norton, N., Moskvina, V., Morris, D. W., Bray, N. J. et al., Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 141, 96-101.
10. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J. et al., Hum. Mol. Genet. 2002, 11, 1373-1380.
11. Millar, J. K., Christie, S., Anderson, S., Lawson, D. et al., Mol. Psychiatry 2001, 6, 173-178.
12. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S. et al., Am. J. Hum. Genet. 2002, 71, 877-892.
13. Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y. et al., Am. J. Hum. Genet. 2002, 71, 337-348.
14. Karson, C. N., Mrak, R. E., Schluterman, K. O., Sturner, W. Q. et al., Mol. Psychiatry 1999, 4, 39-45.
15. Clinton, S. M., Haroutunian, V., Meador-Woodruff, J. H., J. Neurochem. 2006, 98, 1114-1125.
16. Harrison, P. J., Curr. Opin. Neurobiol. 1997, 7, 285-289.
17. Harrison, P. J., Weinberger, D. R., Mol. Psychiatry 2005, 10, 40-68.
18. Singh, S. M., McDonald, P., Murphy, B., O'Reilly, R., Clin. Genet. 2004, 65, 435-440.
19. Lipska, B. K., Jaskiw, G. E., Weinberger, D. R., Neuropsychopharmacology 1993, 9, 67-75.
20. Flores, G., Barbeau, D., Quirion, R., Srivastava, L.K., J. Neurosci. 1996, 16, 2020-2026.
21. Marcotte, E. R., Pearson, D. M., Srivastava, L. K., J. Psychiatry Neurosci. 2001, 26, 395-410.
22. Lipska, B. K., J. Psychiatry Neurosci. 2004, 29, 282-286.
23. Laplante, F., Srivastava, L. K., Quirion, R., J. Neurochem. 2004, 89, 314-323.
24. Laplante, F., Stevenson, C. W., Gratton, A., Srivastava, L. K., Quirion, R., J. Neurochem. 2004, 91, 1473-1482.
25. Laplante, F., Nakagawasai, O., Srivastava, L. K., Quirion, R., Neuropsychopharmacology 2005, 30, 1076-1087.
26. Sams-Dodd, F., Lipska, B. K., Weinberger, D. R., Psychopharmacology (Berl.) 1997, 132, 303-310.
27. Chambers, R. A., Moore, J., McEvoy, J. P., Levin, E. D. Neuropsychopharmacology 1996, 15, 587-594.
28. Schroeder, H., Grecksch, G., Becker, A., Bogerts, B., Hoellt, V., Psychopharmacology (Berl.) 1999, 145, 61-66.
29. Lipska, B. K., Lerman, D. N., Khaing, Z. Z., Weinberger, D. R., Eur. J. Neurosci. 2003, 18, 3097-3104.
30. Flores, G., Alquicer, G., Silva-Gomez, A. B. et al., Neuroscience 2005, 133, 463-470.
31. Kozarova, A., Petrinac, S., Ali, A., Hudson, J. W., J. Proteome Res. 2006, 5, 1051-1059.
32. Wang, S., Cheng, Q., Methods Mol. Biol. 2006, 316, 49-65.
33. Lubec, G., Krapfenbauer, K., Fountoulakis, M., Prog. Neurobiol. 2003, 69, 193-211.
34. Vercauteren, F. G., Bergeron, J. J., Vandesande, F., Arckens, L., Quirion, R., Eur. J. Pharmacol. 2004, 500, 385-398.
35. Vercauteren, F. G. G., Clerens, S., Roy, L., Hamel, N. et al., Mol. Brain Res. 2004, 132, 241-259.
36. Brunet, S., Thibault, P., Gagnon, E., Kearney, P. et al., Trends Cell Biol. 2003, 13, 629-638.
37. Yates, J. R., III, Gilchrist, A., Howell, K. E., Bergeron, J. J., Nat. Rev. Mol. Cell Biol. 2005, 6, 702-714.
38. Kislinger, T., Cox, B., Kannan, A., Chung, C. et al., Cell 2006, 125, 173-186.
39. Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y. et al., Cell 2006, 125, 187-199.
40. Wilkins, M. R., Gasteiger, E., Sanchez, J.-C., Bairoch, A., Hochstrasser, D. F., Electrophoresis 1998, 19, 1501-1505.
41. Santoni, V., Molloy, M., Rabilloud, T., Electrophoresis 2000a, 21, 1054-1070.
42. Santoni, V., Kieffer, S., Desclaux, D., Masson, F., Rabilloud, T., Electrophoresis 2000b, 21, 3329-3344.
43. [431 Paxinos, G., Watson, C. The Rat Brain Atlas in Stereotaxic Coordinates. 4th Edn., Academic Press, New York 1998.
44. Chevallet, M., Santoni, V., Poinas, A., Rouquie, D. et al., Electrophoresis 1998, 19, 1901-1909.
45. Rabilloud, T., Blisnick, T., Heller, M., Luche, S. et al., Electrophoresis 1999, 20, 3603-3610.
46. Luche, S., Santoni, V., Rabilloud, T., Proteomics 2003, 3, 249-253.
47. Yang, B., Steegmaier, M., Gonzalez, L. C., Scheller, R. H., J. Cell Biol. 2000, 148, 247-252.
48. Misura, K. M. S., Scheller, R. H., Weis, W. I., Nature 2000, 404, 355-362.
49. Dulubova, I., Sugita, S., Hill, S., Hosaka, M. et al., EMBO J. 1999, 18, 4372-4382.
50. Mitchell, S. J., Ryan, T. A., Neuropharmacology 2005, 48, 372-380.
51. Graham, M. E., Barclay, J. W., Burgoyne, R. D., J. Biol. Chem. 2004, 279, 32751-32760.
52. Schutz, D., Zilly, F., Lang, T., Jahn, R., Bruns, D., Eur. J. Neurochem. 2005, 21, 2419-2432.
53. Brackmann, M., Schuchmann, S., Anand, R., Braunewell, K. H., J. Cell Sci. 2005, 118, 2495-2505.
54. Ivings, L., Pennington, S. R., Jenkins, R., Weiss, J. L., Burgoyne, R. D., Biochem. J. 2002, 363, 599-608.
55. Tamminga, C., Br. J. Psychiatry 1999, 37, 12-15.
56. Ilouz, N., Branski, L., Parnis, J., Parnas, H., Linial, M., J. Biol. Chem. 1999, 274, 29519-29528.
57. Linial, M., Ilouz, N., Parnas, H., J. Physiol. 1997, 504, 251-258.
58. Liu, Z., Tearle, A. W., Nai, Q., Berg, D. K., J. Neurosci. 2005, 25, 1159-1168.
59. van Koppen, C. J., Biochem. Soc. Trans. 2001, 29, 505-508.
60. Popova, J. S., Rasenick, M. M., J. Biol. Chem. 2004, 279, 30410-30418.
61. Braunewell, K. H., Brackmann, M., Schaupp, M., Spilker, C. et al., J. Neurochem. 2001, 78, 1277-1286.
62. Lin, L., Jeanclos, E. M., Treuil, M., Braunewell, K. H. et al., J. Biol. Chem. 2002, 277, 41872-41878.
63. Kim, K. M., Valenzano, K. J., Robinson, S. R., Yao, W. D. et al., J. Biol. Chem. 2001, 276, 37409-37414.
64. Mundell, S. J., Matharu, A. L., Pula, G., Holman, D. et al., Mol. Pharmacol. 2002, 61, 1114-1123.
65. Luis Albasanz, J., Fernandez, M., Martin, M., Brain Res. Mol. Brain Res. 2002, 99, 54-66.
66. Petralia, R. S., Wang, Y. X., Wenthold, R. J., Eur. J. Neurosci. 2003, 18, 3207-3217.
67. Pula, G., Mundell, S. J., Roberts, P. J., Kelly, E., J. Neurochem. 2004, 89, 1009-1020.
68. Nong, Y., Huang, Y. Q., Ju, W., Kalia, L. V. et al., Nature 2003, 422, 302-307.
69. Nakamichi, N., Yoneda, Y., J. Pharmacol. Sci. 2005, 97, 348-350.
70. Roth, B. L., Willins, D. L., Kristiansen, K., Kroeze, W. K., Pharmacol. Ther. 1998, 79, 231-257.
71. Parker, S. L., Parker, M. S., Lundell, I., Balasubramaniam, A. et al., Regul. Pept. 2002, 107, 49-62.
72. Pheng, L. H., Dumont, Y., Fournier, A., Chabot, J. G. et al., Br. J. Pharmacol. 2003, 139, 695-704.
73. Ojika, K., Mitake, S., Tohdoh, N., Appel, S. H. et al., Prog. Neurobiol. 2000, 60, 37-83.
74. Jope, R. S., Jenden, D. J., J. Neurochem. 1980, 35, 318-325.
75. Wallimann, T., Waltzthony, D., Wegmann, G., Moser, H. et al., J. Cell. Biol. 1985, 100, 1063-1072.
76. Hu, D., Cao, K., Peterson-Wakeman, R., Wang, R., Biochem. Biophys. Res. Commun. 2002, 297, 729-736.
77. Hyde, T. M., Crook, J. M., J. Chem. Neuroanat. 2001, 22, 53-63.
78. Andres, R. H., Ducray, A. D., Huber, A. W., Perez-Bouza, A. et al., J. Neurochem. 2005, 95, 33-45.
79. Waagepetersen, H. S., Sonnewald, U., Schousboe, A., Neuroscientist 2003, 9, 398-403.
80. Andres, R. H., Huber, A. W., Schlattner, U., Perez-Bouza, A. et al., Neuroscience 2005, 133, 701-713.
81. Andreasen, N. C., O'Leary, D. S., Flaum, M., Nopoulos, P. et al., Lancet 1997, 349, 1730-1734.